HealthDay - SATURDAY, March 29 (HealthDay News) -- medicine with a new
antiplatelet drug called prasugrel may be better than standard treatment
in protecting against blocked blood flow in clientele with at least one
coronary stent, by the numbers to a new international study.

More: - Brought to my attention by